Comparison of Four Renal Function Estimation Equations for Pharmacokinetic Modeling of Gentamicin in Geriatric Patients

被引:23
作者
Charhon, Nicolas [1 ]
Neely, Michael N. [2 ]
Bourguignon, Laurent [1 ,3 ]
Maire, Pascal [1 ,3 ]
Jelliffe, Roger W. [2 ]
Goutelle, Sylvain [1 ,3 ,4 ]
机构
[1] Hosp Civils Lyon, Grp Hosp Geriatrie, Serv Pharmaceut ADCAPT, Lyon, France
[2] USC Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA USA
[3] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France
[4] Univ Lyon 1, Fac Pharm Lyon ISPB, F-69365 Lyon, France
关键词
PREDICTING AMINOGLYCOSIDE ELIMINATION; COCKCROFT-GAULT FORMULAS; CREATININE CLEARANCE; DOSAGE REGIMENS; POPULATION PHARMACOKINETICS; ELDERLY-PATIENTS; SURFACE-AREA; TARGET GOALS; WEIGHT; NETILMICIN;
D O I
10.1128/AAC.05634-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most aminoglycoside pharmacokinetic models include an index of renal function, such as creatinine clearance, to describe drug clearance. However, the best clinical descriptor of renal function for the pharmacokinetic modeling of aminoglycosides has not been established. This analysis was based on 412 gentamicin concentrations from 92 geriatric patients who received intravenous gentamicin for various infectious diseases. Four two-compartment population models were fitted to gentamicin concentrations in a learning set of 64 patients using the nonparametric adaptive grid (NPAG) algorithm. Each model included an index of renal function, namely, the Cockcroft-Gault (CG), Jelliffe (JEL), modification of diet in renal disease (MDRD), or modified MDRD (MDRDm; adjusted to individual body surface area) equation as a covariate influencing gentamicin serum clearance. Goodness of fit and predictive performance of the four models were compared using standard criteria in both the learning set and in a validation set of 28 patients. A final analysis was performed to estimate the population pharmacokinetic parameter values of the entire 92-patient group. In the learning set, the CG-based model best fit the data, followed by JEL-, MDRD-, and MDRDm-based models, with relative reductions of the Akaike information criterion of 29.4, 20.2, 14.2, and 4.2, respectively. Bias and precision of population predictions were significantly different among the four models. In the validation set, individual predictions from the four models showed marginally different biases. The final estimation confirmed the previous results. Specifically, the CG-based model showed predictive performance that was comparable to or better than that of the MDRD-based model at each stage of the analysis. This study shows that methods used to estimate renal function should not be considered interchangeable for the model-based estimation of gentamicin concentrations.
引用
收藏
页码:1862 / 1869
页数:8
相关论文
共 41 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]   Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity [J].
Avent, M. L. ;
Rogers, B. A. ;
Cheng, A. C. ;
Paterson, D. L. .
INTERNAL MEDICINE JOURNAL, 2011, 41 (06) :441-449
[3]   INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
EDWARDS, WAD ;
DELLINGER, EP ;
SIMONOWITZ, DA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :643-647
[4]  
BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597
[5]   Modification of Diet in Renal Disease and Modified Cockcroft-Gault Formulas in Predicting Aminoglycoside Elimination [J].
Bookstaver, P. Brandon ;
Johnson, James W. ;
McCoy, Thomas P. ;
Stewart, David ;
Williamson, John C. .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) :1758-1765
[6]   Amikacin Pharmacokinetics in Adults: a Variability That Question the Dose Calculation Based on Weight. [J].
Bourguignon, Laurent ;
Goutelle, Sylvain ;
Gerard, Cecile ;
Guillermet, Anne ;
de Saint Martin, Julie Burdin ;
Maire, Pascal ;
Ducher, Michel .
THERAPIE, 2009, 64 (01) :47-53
[7]   Stature prediction equations for elderly non-Hispanic white, non-Hispanic black, and Mexican-American persons developed from NHANES III data [J].
Chumlea, WC ;
Guo, SS ;
Wholihan, K ;
Cockram, D ;
Kuczmarski, RJ ;
Johnson, CL .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1998, 98 (02) :137-142
[8]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[9]   AMINOGLYCOSIDE PHARMACOKINETICS - VOLUME OF DISTRIBUTION IN SPECIFIC ADULT PATIENT SUBGROUPS [J].
DAGER, WE .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (7-8) :944-951
[10]  
Debord J, 1997, INT J CLIN PHARM TH, V35, P24